Other languages Sanara MedTech Inc.

Equities

SMTI

US79957L1008

Market Closed - Nasdaq Other stock markets 21:00:00 01/05/2024 BST			5-day change	1st Jan Change
31.23 ^USD	-1.92%		-3.91%	-24.01%

04-18	Sanara Medtech Inc. Announces $55 Million Debt Facility	CI
04-05	Sanara MedTech Appoints Jake Waldrop as Chief Operating Officer	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sanara MedTech Appoints Jake Waldrop as Chief Operating Officer	04-05
Sanara MedTech Inc. Announces Executive Changes, Effective April 15, 2024	04-05
Sanara MedTech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-25
Sanara MedTech Reports Higher Preliminary Q4 Revenue	02-22
Sanara MedTech Secures Exclusive Licensing Deal with Tufts University for 18 Collagen Peptides	01-03
Sanara MedTech Q3 Loss Narrows, Revenue Rises; Shares Fall After Hours	11-13
Sanara MedTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13
Sanara MedTech Inc. Announces BIASURGE Advanced Surgical Solution Updates	10/10/23
Sanara MedTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Sanara MedTech Acquires Selected Assets Related to Its Collagen Products Business	02/08/23
Sanara MedTech Inc. acquired Certain Assets Related to its Collagen Products Business from Applied Nutritionals, LLC, The Hymed Group Corporation, and Dr. George Petito for 25.3 million.	01/08/23
Sanara MedTech Inc. Elects Robert Desutter as Board of Director	06/06/23
Sanara MedTech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Sanara MedTech Says it Received 510(k) Clearance for Biasurge Surgical Product	04/04/23
Sanara MedTech Reports Rising Preliminary Q4 Revenue	22/02/23
Sanara MedTech Inc. Provides Preliminary Earnings Guidance for the Fourth Quarter and Full-Year 2022	22/02/23
Sanara MedTech Inc. Announces Resignation of Shawn M. Bowman as President, Strategic Partnerships	06/12/22
Sanara MedTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Sanara MedTech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	15/08/22
Sanara MedTech Completes Acquisition of Scendia Biologics for $7.4 Million	05/07/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sanara MedTech Inc.

Equities

SMTI

US79957L1008

Other languages

Filters